Novel recombinant human hepatitis C virus-like particle and method for producing the same

Details for Australian Patent Application No. 2006295716 (hide)

Owner JAPAN as represented by DIRECTORGENERAL of National Institute of Infectious Diseases Toray Industries, Inc. Tokyo Metropolitan Institute of Medical Science

Inventors Tanabe, Jun-Ichi; Miyamura, Tatsuo; Suzuki, Tetsuro; Ishii, Koji; Wakita, Takaji; Suzuki, Ryosuke; Sone, Saburo

Agent Davies Collison Cave

Pub. Number AU-B-2006295716

PCT Pub. Number WO2007/037429

Priority 2005-287825 30.09.05 JP

Filing date 29 September 2006

Wipo publication date 5 April 2007

Acceptance publication date 3 November 2011

International Classifications

C12N 7/00 (2006.01) Viruses, e.g. bacteriophages

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

Event Publications

15 May 2008 PCT application entered the National Phase

  PCT publication WO2007/037429 Priority application(s): WO2007/037429

20 October 2011 Alteration of Name

  The name of the applicant has been altered to JAPAN as represented by DIRECTOR-GENERAL of National Institute of Infectious Diseases; Toray Industries, Inc.; Tokyo Metropolitan Institute of Medical Science

3 November 2011 Application Accepted

  Published as AU-B-2006295716

1 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006295717-T-cell adhesion molecule and antibody directed against the molecule

2006295714-Tissue closing device